Nanomatronix

Nanomatronix is an engineering and technology development firm that provides solutions for the energy, aerospace, defense, and healthcare industries by leveraging expertise in nanotechnology, microelectronics, and biotechnology. The company acts as a technology transfer partner, helping to transition research and development from academic and laboratory settings into applied commercial products. Its technical capabilities include the design, prototyping, and qualification of application-specific integrated circuits (ASICs), hybrid microcircuits, and fiber optic networking transceivers intended for harsh environments, as well as the synthesis of nanomaterials such as carbon nanotubes and metal-oxide nanofibers.

By utilizing Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) mechanisms, Nanomatronix collaborates with researchers to bridge the gap between early-stage innovation and market-ready solutions. A significant area of focus is its AMBIT platform, an organ-on-chip technology designed to model blood-brain barrier responses and traumatic brain injury, which serves as a tool for drug screening and precision medicine. The company offers standardized screening and qualification services—including radiation and environmental testing—to ensure that systems meet rigorous Department of Defense, NASA, and industry-specific standards.